JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Moore, J. I.
Right arrow Articles by Cotten, M. deV.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Moore, J. I.
Right arrow Articles by Cotten, M. deV.
Journal of Pharmacology And Experimental Therapeutics, Vol. 155, Issue 2, 250-258, 1967
Copyright © 1967 by American Society for Pharmacology and Experimental Therapeutics


INFLUENCE OF NOREPINEPHRINE AND OUABAIN ON CARDIAC MUSCLE MECHANICS DURING HYPOTHERMIA

Joanne I. Moore 1 and Marion deV. Cotten 1

1 Department of Pharmacology, University of Oklahoma School of Medicine, Oklahoma City, Oklahoma

Analysis of the mechanics of cardiac contraction in anesthetized, open chest dogs at normal body temperature showed that norepinephrine increased contractile force, rate of contraction (dT/dt), integrated systolic force (ISF), heart rate and blood pressure, and decreased the time for development of peak force and duration of the cardiac cycle in proportion to the dose. When body temperature was lowered to 28-30°C, contractile force, dT/dt and heart rate were decreased, and the time to peak force and durations of the relaxation phase and total cardiac cycle were increased. At 28-30°, a small dose of norepinephrine only stimulated the heart, but 1 µg/kg of norepinephrine caused a triphasic pattern in contractile force, dT/dt, ISF and duration of relaxation characterized by an initial, brief increase, a transient decrease and final prolonged increase. The time to peak force decreased markedly during the first phase, underwent a slight additional shortening in the second phase and returned slowly to control during the third phase. Ouabain given during hypothermia increased force, dT/dt, ISF and blood pressure, but did not alter the other parameters. Norepinephrine after ouabain only decreased contractile force, dT/dt, ISF, time to peak force and duration of the cardiac cycle. The decrease in dT/dt, but not the decrease in the time to peak force, was shown to be the principal cause of the negative inotropic response to norepinephrine in the dog during hypothermia.

Submitted on May 23, 1966
Accepted on August 25, 1966







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1967 by the American Society for Pharmacology and Experimental Therapeutics.